Biomol Ther.  2015 Jul;23(4):339-344. 10.4062/biomolther.2015.024.

Anti-Proliferative Effect of Naringenin through p38-Dependent Downregulation of Cyclin D1 in Human Colorectal Cancer Cells

Affiliations
  • 1Department of Bioresource Sciences, Andong National University, Andong 760-749, Republic of Korea. jjb0403@anu.ac.kr
  • 2Gyeongbuk Institute for Bio-industry, Andong 760-380, Republic of Korea.
  • 3Insititute of Agricultural Science and Technology, Andong National University, Andong 760-749, Republic of Korea.

Abstract

Naringenin (NAR) as one of the flavonoids observed in grapefruit has been reported to exhibit an anti-cancer activity. However, more detailed mechanism by which NAR exerts anti-cancer properties still remains unanswered. Thus, in this study, we have shown that NAR down-regulates the level of cyclin D1 in human colorectal cancer cell lines, HCT116 and SW480. NAR inhibited the cell proliferation in HCT116 and SW480 cells and decreased the level of cyclin D1 protein. Inhibition of proteasomal degradation by MG132 blocked NAR-mediated cyclin D1 downregulation and the half-life of cyclin D1 was decreased in the cells treated with NAR. In addition, NAR increased the phosphorylation of cyclin D1 at threonine-286 and a point mutation of threonine-286 to alanine blocked cyclin D1 downregulation by NAR. p38 inactivation attenuated cyclin D1 downregulation by NAR. From these results, we suggest that NAR-mediated cyclin D1 downregulation may result from proteasomal degradation through p38 activation. The current study provides new mechanistic link between NAR, cyclin D1 downregulation and cell growth in human colorectal cancer cells.

Keyword

Naringenin; Cyclin D1; Cancer chemoprevention; Human colorectal cancer

MeSH Terms

Alanine
Cell Line
Cell Proliferation
Citrus paradisi
Colorectal Neoplasms*
Cyclin D1*
Down-Regulation*
Flavonoids
Half-Life
Humans
Phosphorylation
Point Mutation
Alanine
Cyclin D1
Flavonoids
Full Text Links
  • BT
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr